Greenbrook TMS Inc., a Bristol Investor Relations client, announced its third quarter 2022 operational and financial results. Some highlights included: Revenue for Q3 2022 increased by 58% to a record high of $20.8 million as compared to the third quarter of 2021. Quarterly treatment volumes in Q3 2022 increased by 74% to a record high of 95,046 as compared to Q3 2021. Consultations performed in Q3 2022 increased by 156% to a record high of 8,797 as compared to Q3 2021, while new patient starts increased by 87% to 2,848 as compared to Q3 2021. These increases were predominately due to the additional TMS Centers acquired by the Company in connection with the Success TMS acquisition.

Read the full press release here: Greenbrook TMS Reports Third Quarter Operational and Financial Results